🇺🇸 Pegulicianine in United States

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

FDA authorised Pegulicianine on 17 April 2024

Marketing authorisations

FDA — authorised 17 April 2024

Application: NDA214511
Marketing authorisation holder: LUMICELL
Local brand name: LUMISIGHT
Indication: POWDER — INTRAVENOUS
Status: approved

Read official source →

FDA

Status: approved

Other Other approved in United States

Frequently asked questions

Is Pegulicianine approved in United States?

Yes. FDA authorised it on 17 April 2024; FDA has authorised it.

Who is the marketing authorisation holder for Pegulicianine in United States?

LUMICELL holds the US marketing authorisation.